COVID-19: An insight into the developments in diagnostics and therapeutics in India

Author:

Rao Vishal1,Kannan Swetha12,Kumar Jitendra3,Arakeri Gururaj4,Subash Anand1,Batra H. V.5,Gulia Ashish6

Affiliation:

1. Department of Head and Neck Surgical Oncology, HCG Cancer Hospital, Bengaluru, Karnataka, India,

2. School of Biological Sciences, University of Edinburgh, Edinburgh, UK,

3. Bangalore Bio-Innovation Centre, Helix Biotech Park, Electronics City Phase 1, Electronic City, Bengaluru, Karnataka, India,

4. Department of Oral and Maxillofacial Surgery, Navodaya Dental College, Raichur, Karnataka, India,

5. Bommasandra Industrial Estate, Shankaranaraya Life Sciences, Bengaluru, Karnataka, India,

6. Bone and Soft Tissue, Tata Memorial Hospital, Mumbai, Maharashtra, India,

Abstract

The unexpected pandemic set off by the novel coronavirus (SARS-CoV2) has spread to more than 210 countries across the globe, including India. In the current pandemic situation, various steps have been taken by the Indian government to prevent and control the spread of the SARS-CoV2 infection. To date, there are no proven vaccines or effective therapeutic interventions against the virus. Current clinical management includes infection prevention and control, symptom-specific relief and supportive care. Physicians and scientists across the country have been tirelessly working on developing effective diagnostic and therapeutic strategies and to combat and control this infection. As the demand for diagnostics and therapeutics continues to rise in India and around the globe, it is essential to rapidly develop various algorithms to successfully identify and contain the virus. This review discusses the updates on the recent developments in COVID-19 diagnostics and therapeutics in India.

Publisher

Scientific Scholar

Subject

General Medicine

Reference30 articles.

1. ICMR COVID Team Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020;Gupta;Indian J Med Res,2020

2. Systemic effects of SARS-CoV: A brief insight;Singhai;Indian J Med Spec,2003

3. When COVID-19 will decline in India? Prediction by combination of recovery and case load rate;Bhattacharjee;Clin Epidemiol Global Health,2020

4. Why are Indians having lower incidence of infections and deaths due to the COVID-19 virus?;Parikh;Indian J Med Sci,2020

5. Nucleic acid-based methods for the detection of bacterial pathogens: Present and future considerations for the clinical laboratory;Mothershed;Clin Chim Acta,2006

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3